Skip to main content
. 2018 Nov 13;9:1297. doi: 10.3389/fphar.2018.01297

FIGURE 1.

FIGURE 1

Effects of N-myristoylation of CM4 on the structure and cytotoxicity to breast cancer cells and normal cells. (A) Secondary structure analysis by CD spectroscopy. Far-UV CDspectra were conducted at room temperature in TFE/water mixtures at 50% (v/v). Peptide concentration was 250 μg/mL. (B) Comparison of the cell viability of three breast cell lines and two normal cell lines after treated by different concentration of myristoyl-CM4 and CM4 by MTT assay. (C) Hemolytic activity was tested by mouse erythrocytes. Melittin was used as a control. All assays were performed as described in section 2. Results are mean ± SEM of 4–6 different experiments.